My point is that there is an anti-science faction that has made the abortion debate their only "driving force". hESC's are part of that debate, and that was important to Geron before IMET. They lie, murder and they are fraudulent.
There really is only one game in town for Geron, and that is the performance of its big brother JNJ-Janssen at the IMET trials. This is a make or break situation.
The dangerous ones (fascist, religious extremists, anti-science, anti-Geron, pro-gun) are all far right and support the Grand Old Party or revolution.
Why is Geron crashing?
1. IMET medical failure? No
2. Foreign Selling? Maybe
3. Margin Calls? Perhaps
4. JNJ Loss of Interest? No
5. Hedge-funds? Maybe
6. Geron Corruption? Probably Not
7. IMET not Safe or Effective? No
8. Macro Market? Partly
The medical successes are still intact. Only an IMET medical failure should cause this kind of a selloff, but that has not happened.
The data and analyses from the JNJ trials will be coming soon. This news hopefully will confirm the Mayo Clinic successes, and add to the revelations in the NEJM articles and the ASH presentations.
ASH, NEJM articles, and good trial data should be the dominant forces (all positive developments). Geron, with one medicine, should be least influenced by macro markets. Manipulations and "magic algorithms" are major factors.
Geron & IMET are involved in several "markets"
1. JNJ medical trials market (remissions and cures)--most important
2. Small biotech market (hedge funds and manipulators)--wild swings
3. Macro market (China and other political/ economic news)
There are no problems with IMET. It is a "transformative" and "platform" medicine in the treatment of blood cancers, and perhaps all cancers.
The State of the Union was very clear: Joe Biden's new job is to advance the treatment for cancer, and "find a cure, when possible". IMET is a major component that fits into this equation as a useful medicine (telomere and telomerase considerations) by itself and in combination. The "platform-nature" of Imetelstat will increase the importance of this medicine. JNJ is in the right place at the right time, with a medicine that may have applications in all forms of cancer. IMET is part of the cure.
As long as the medical news (Mayo and JNJ trials for IMET) continues to be good, there is nothing to worry about for long term investors.
What could possibly go wrong at this late date. There are no significant safety issues, and IMET brings remission and cures where all others fail.
No one would pursue a marginal drug with such vigor over such a vast territory (the whole world) unless they knew that it was very, very good. JNJ has that knowledge.
IMET, as a "transformative drug", has nothing to do with China, North Korea or the middle-east. It should have a "green day" tomorrow. JNJ and Mayo Clinic have not delivered any IMET bad news that could crush Geron.
We tried that in 1950 (the Korean-Chinese War) and China knocked the S##T out of us (Truman fired Macarthur--"Old soldiers never die--". We still have about 30,000 USA soldiers on the border between the two Koreas. China has the home field advantage, and will take care of Mr. Un in due time. The middle-eastern wars (Islam, Christian, Jewish) go back to the Crusades and have no solution. None of this affects IMET.
Geron's PPS should bounce back to over $5, since nothing that has happened diminishes IMET in any way. The Morgan Health Conference will also help.
Un (NK's leader) is better at upsetting markets than building bombs or running a country. The world has nuclear fears. I believe almost everyone wants to get rid of North Korea as it now exists. That will be messy, since Un appears to be desperate, which makes him unpredictable. This is a China problem more than ours, since it is on their borders. They see what is happening in Europe, and fear a panicked mass exodus.